Overview

Founded in 2007, Sequent Medical, Inc. is a privately-held venture backed medical device company dedicated to the development of innovative catheter-based neurovascular technologies. The company has invented and developed the WEBâ„¢ Aneurysm Embolization System. The WEB Aneurysm Embolization System has received the CE mark. In the United States it is an investigational device limited by United States law to investigational use. Sequent Medical, Inc. is headquartered in Aliso Viejo, California and has European operations based in Bonn, Germany.

About The WEB-IT Study
The WEB-IT Study, a US Investigational Device Exemption (IDE) Study, is a prospective, multicenter, single-arm study evaluating the WEB in 150 patients with ruptured or unruptured wide neck intracranial bifurcation aneurysms. The study will be conducted at 30 investigational sites, including 25 in the United States. More information on the WEB-IT study can be found at www.clinicaltrials.gov under NCT# 02191618.




CAUTION: The WEB Aneurysm Embolization System is an investigational device limited by United States law to
investigational use.